The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LIX.e

Pneumocystis jiroveci pneumonia

Publications

Wan QJ, Hu HF, He YC, Luan SD, Chen HT, Liu HP, Li T, Xu Y, Xu HL, Liao Y

Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy.

The Kaohsiung journal of medical sciences 2015 Jan;31;42-6 — 2015 Jan — 42-6

Zhang Y, Zheng Y

Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases.

Rheumatology international 2014 Dec;34;1765-71 — 2014 Dec — 1765-71

Neff RT, Jindal RM, Yoo DY, Hurst FP, Agodoa LY, Abbott KC

Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia.

Transplantation 2009 Jul 15;88;135-41 — 2009 Jul 15 — 135-41